Table 2 Disease recurrence according to demographic and histologic parameters, in 55 patients
From: Expression of heparanase in soft tissue sarcomas of adults
Characteristic | No. of patients out of entire group (%) | No. of patients with recurrent disease (% of each sub group) | Disease recurrence p value | |
|---|---|---|---|---|
Age | <40 | 13 (24%) | 5 (38.5%) | 0.73 |
40-59 | 9 (16%) | 4 (44.4%) | ||
60-69 | 14 (25%) | 8 (57.1%) | ||
>70 | 19 (35%) | 10 (52.6%) | ||
Gender | Male | 33 (60%) | 16 (48.5%) | 0.44 |
Female | 22 (40%) | 12 (54.2%) | ||
Pathological type | Malignant fibrous histiocytoma | 19 (35%) | 12 (66.7%) | 0.67 |
Liposarcoma | 8 (15%) | 3 (37.5%) | ||
Leiomyosarcoma | 6 (11%) | 4 (66.6%) | ||
Angiosarcoma | 2 (4%) | 0 | ||
Chondrosarcoma | 5(8%) | 1 (20%) | ||
Synovial sarcoma | 4 (7%) | 3 (75%) | ||
NOS | 11 (20%) | 5 (45.5%) | ||
Grade | Low | 15 (27%) | 0 | 0.01> |
Intermediate | 3 (5%) | 1 (33%) | ||
High | 37 (67%) | 27 (73%) | ||
Stage | I | 18 (33%) | 1 (5.5%) | 0.01> |
II | 4 (7%) | 3 (75%) | ||
III | 33 (60%) | 24 (73%) | ||
Level of heparanase expression | No staining | 5 (9%) | 3 (60%) | |
Weak staining | 18 (33%) | 10 (55%) | 0.77 | |
Strong staining | 32 (58%) | 15 (47%) | ||